DB05303InvestigationalSmall molecule
OMS103HP is the first drug being developed to improve joint function following arthroscopic surgery, one of the most common procedures performed today by orthopedic surgeons.
- Mechanism
- Curator reviewed
OMS-103HP is used to inhibit inflammation and pain associated with arthroscopy, provided statistically significant improvement in postoperative pain reduction, joint motion and recovery of function. It is a unique product that is added to standard irrigation solutions and perfused through the joint during arthroscopic surgery.
- Primary indication
- Investigated for use/treatment in inflammatory disorders (unspecified), knee replacement, orthopedic surgery, and pain (acute or chronic).Curator reviewed
- Code names
- OMS-103HP
Resolves to
Targets
What you can answer from here — as of April 23, 2025
2Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with OMS-103HP, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account